Allspring Global Investments
ZYME icon

Allspring Global Investments’s Zymeworks ZYME Stock Holding History

Allspring Global Investments’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
8,762
+255
+3% +$6.48K ﹤0.01% 1638
2026
Q1 		$221K Buy
8,507
+800
+10% +$18.9K ﹤0.01% 1586
2025
Q4 		$205K Buy
+7,707
New +$168K ﹤0.01% 1575
2024
Q4 		– Sell
-696
Closed -$8.73K – 2453
2024
Q3 		$8.73K Hold
696
– – ﹤0.01% 2107
2024
Q2 		$5.92K Sell
696
-142,519
-100% -$1.27M ﹤0.01% 2219
2024
Q1 		$1.51M Sell
143,215
-84,410
-37% -$937K ﹤0.01% 1263
2023
Q4 		$2.37M Buy
227,625
+38,181
+20% +$304K ﹤0.01% 1134
2023
Q3 		$1.2M Buy
189,444
+148,212
+359% +$1.09M ﹤0.01% 1322
2023
Q2 		$356K Buy
41,232
+2,187
+6% +$19.6K ﹤0.01% 1640
2023
Q1 		$353K Buy
39,045
+746
+2% +$6.5K ﹤0.01% 1674
2022
Q4 		$301K Sell
38,299
-5,628
-13% -$39.5K ﹤0.01% 1732
2022
Q3 		$270K Buy
43,927
+21,407
+95% +$129K ﹤0.01% 1733
2022
Q2 		$119K Buy
22,520
+4,226
+23% +$25.6K ﹤0.01% 1999
2022
Q1 		$119K Hold
18,294
– – ﹤0.01% 2713
2021
Q4 		$299K Buy
+18,294
New +$381K ﹤0.01% 2514

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Allspring Global Investments's ZYME Position: Q2 2026 in Review

Allspring Global Investments increased its Zymeworks (ZYME) stake by 3% in Q2 2026, buying an estimated $6.48K and bringing the position to 8,762 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Allspring Global Investments first reported a position in ZYME in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.37M in Q4 2023. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Allspring Global Investments held 8,762 shares of Zymeworks worth $225K as of Q2 2026.
  • Allspring Global Investments bought 255 Zymeworks shares in Q2 2026, an estimated $6.48K.
  • Zymeworks made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1638 holding.
  • Allspring Global Investments first reported a position in Zymeworks in Q4 2021 and has held it in 15 quarters since.
  • Allspring Global Investments's Zymeworks position peaked at $2.37M in Q4 2023.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.